Be smarter and faster with PRO Alerts on ATNM
From other sites
There is research on this stock available only to PRO subscribers.
There are no Related articles on ATNM.
There are no Transcripts on ATNM.
Wed, Jun. 25, 12:47 PM
Wed, Jun. 25, 10:49 AM
- Actinium Pharmaceuticals (ATNM -16.1%) prices its public offering of 1.67M shares of common stock at $7.50 per share. Underwriters over-allotment is 250K shares. Closing date is June 30.
- Net proceeds of $11.4M will be used to advance Actimab-A and Iomab-B, support preclinical activities and for general corporate purposes.
ATNM vs. ETF Alternatives
Other News & PR